-
Be careful not to hit the pit of the contrast agent!
Time of Update: 2021-06-22
Low toxicity, low osmotic pressure and non-ionic iodine contrast agents have been used in more and more clinical applications, but the side effects and adverse reactions that follow are also called influences.
-
Bayer strongly deploys Parkinson's innovative therapies, stem cell and gene therapy have entered the clinical stage, Yi Mai Meng broke the news
Time of Update: 2021-06-22
Recent popular reports from Yimaike ★ Invitation to the grand event 2021 Oncolytic Virus Drug Development Forum is about to open in Shanghai ★ The financing has been hundreds of millions in half a ye
-
[New research] At what age do you remember your earliest memory?
Time of Update: 2021-06-22
Author: Yun Introduction: Researchers believe that most adults have "childhood amnesia" and can't remember things about infants and young children .
Research shows that, on average, the earliest memories people can recall can be traced back to when they were two and a half years old .
-
The patient has skin itching and cramps, this disease cannot be ignored!
Time of Update: 2021-06-22
When Zhou Feng was seeing Xiong Qing, she was once confused by her skin itching, because of the core symptoms of NMOSD, including: optic neuritis, long-segment myelitis, and posterior zone syndrome (refractory hiccups and vomiting) ), diencephalic syndrome (drowsiness), etc.
-
Are men "thinking with the lower body" being hammered?
Time of Update: 2021-06-22
The brain is the most advanced part of the nervous system, which dominates all human activities, including language production, memory storage, thought and emotion formation, and the testis is the male reproductive organ, used to produce sperm and Synthesize and secrete hormones (mainly testosterone) .
-
Express has shown efficacy for SMA patients aged 1-60 years, and the latest clinical results of Roche's innovative oral therapy are positive
Time of Update: 2021-06-22
The latest data from the trial showed that in patients between 1 and 60 years old who had previously received other SMA therapies, Evrysdi more than doubled the level of SMN protein, and the safety was consistent with previous studies .
-
Courier treatment of Alzheimer's disease, Phase 2 clinical results of innovative tau protein vaccine published
Time of Update: 2021-06-22
▎The content team editor of WuXi AppTec today, Axon Neuroscience announced that the complete results of the Phase 2 clinical trial of its tau protein vaccine AADvac1 for the treatment of Alzheimer's disease (AD) were published in the sub-published Nature Aging .
-
Want a good night's sleep?
Time of Update: 2021-06-22
"The study found that many people who have the habit of listening to music experience a continuous "earworm effect" and a decline in sleep quality .
-
How to choose Parkinson's treatment drugs?
Time of Update: 2021-06-22
For patients with early-onset (onset between 40 and 50 years of age) Parkinson's without cognitive dysfunction, the choice of drugs varies according to the clinical manifestations: anticholinergics are the main choice for tremor .
-
Nature: FDA approved a landmark new drug, patients are happy, scholars are worried...
Time of Update: 2021-06-22
S. Food and Drug Administration (FDA) approved Aducanumab, the first new drug to treat Alzheimer's disease in 18 years .
Some scientists say that if it proves that reducing the activity of amyloid is sufficient to win regulatory approval, it may prevent researchers from focusing on the huge cognitive improvements needed for patients .
-
The latest advances in the diagnosis and treatment of perforator atherosclerosis｜CNA 2021
Time of Update: 2021-06-22
On the one hand, the current newer WB-VWI technology can display LSA, but it cannot display other smaller diameter perforating arteries, such as PPA; on the other hand, the mechanism and treatment of clinical BAD patients’ disease progression is still in the research stage .
-
Nothing to do with beta amyloid!
Time of Update: 2021-06-22
In April last year, the team of Professor Berislav Zlokovic of the University of Southern California published an article in the journal Nature, revealing the mystery behind it: It turns out that this gene can cause degenerative changes in the capillary pericytes of the brain and accelerate the blood-brain barrier.
-
Theranostics: Serotonin/HTR1E signal blocking chronic...
Time of Update: 2021-06-22
In the end, the authors discovered the important role of serotonin/HTR1E signaling in preventing the progression of OC promoted by chronic psychological stress, suggesting that HTR1E specific agonists and SRC inhibitors have potential therapeutic value for OC patients suffering from psychological stress .
-
You lie flat, your brain is still learning 20 times faster
Time of Update: 2021-06-22
A new study published recently also found that in a waking and resting state, brain activity can "play back" the sequence of actions just learned at 20 times the speed.
-
Deciphering the detailed structure of Parkinson’s disease-causing proteins, Sun Ji’s research group opens up new ways for the development of new drugs
Time of Update: 2021-06-22
This result provides structural insights for the development of new therapies to treat Parkinson's disease, and opens up a research approach that specifically targets abnormal LRRK2 proteins .
-
How to diagnose central vertigo?
Time of Update: 2021-06-22
How to locate and qualitatively diagnose localized diagnosis: middle-aged and elderly women with chronic onset, progressive progression, unstable walking, denial of family genetic history Physical examination: difficulty in sitting up, gaze-induced nystagmus (+), bilateral Pap's sign (+), bilateral finger-nose and heel-knee tibial tests (+), combined with imaging findings for structural atrophy of the cerebellum, consider positioning In the cerebellum and bilateral pyramidal tract damage .
-
Understand in one article, how to choose Parkinson's treatment drugs
Time of Update: 2021-06-22
For patients with early-onset (onset between 40 and 50 years of age) Parkinson's without cognitive dysfunction, the choice of drugs varies according to the clinical manifestations: anticholinergics are the main choice for tremor .
-
Lysogene's AAV gene therapy for GM1 gangliosidosis completes the first patient's administration
Time of Update: 2021-06-22
Recent popular reports from Yimaike ★ Invitation to the grand event 2021 Oncolytic Virus Drug Development Forum is about to open in Shanghai ★ The financing has been hundreds of millions in half a ye
-
EHJ: Exercise well to prevent stroke and atrial fibrillation!
Time of Update: 2021-06-22
A recent study published in the European Heart Journal showed that in accordance with various authoritative guidelines, middle-aged and elderly people should exercise more than 150 minutes of moderate-to-high intensity exercise per week, which would reduce the risk of atrial fibrillation by 18% and the occurrence of stroke.
-
CStone and Pfizer collaborate to further upgrade and jointly develop new lung cancer drug loratinib in China
Time of Update: 2021-06-22
On June 15, CStone Pharmaceuticals announced that the company and Pfizer will jointly develop a new drug for ROS1-positive lung cancer patients in the Greater China region-lorlatinib .
